Apo-CIII levels and variation in the APOC3 gene contribute to dyslipidaemia, artery wall inflammation, atherogenesis, and cardiovascular disease (CVD) risk [9,10,11]. Here, APOC3 is linked to inherited lipid metabolism disorder.